I would suggest that in the next 5 years or so if ozempic and others don't turn out to be cancer causing or have more than awful side effects that we'll see a large drop in obesity, as obesity isn't an easy thing to change. Likely other competitors will come along and use a similar mechanism and Novo won't be able to charge $1000 a month for it any longer allowing 80-85% of those who are overweight to give it a shot.